Pharmaceutical grade sodium chloride is mainly used in peritoneal dialysis, mechanical cleansing solutions, ORS and others. North America is expected to have the largest market for pharmaceutical grade sodium chloride. However, the Asia Pacific region would emerge as the largest market due to its increasing spending capacity in .
Rapid increase in patients with chronic as well as kidney diseases is driving the market worldwide. In addition, strong need for pharmaceutical grade sodium chloride mainly in Europe and North America has also contributed to the growth of the market. Strict policies or regulation initiated by the government bodies has hampered the growth of the market. Likewise, low profitability has also obstructed the growth of the market. However, pure and certified salt and growing spending capability in developing countries is expected to create greater opportunities.
The market is segmented based on application and geography. The types assessed in the market research report are channeling agents/ osmotic agent, mechanical cleansing solutions, peritoneal dialysis, & hemofiltration solutions, injections, hemodialysis, oral rehydration salts (ORS) and others. Regions such as North America, Europe, Asia Pacific and LAMEA would experience rapid growth.
The key market players active in the pharmaceutical grade sodium chloride market are Hub Salt, AkzoNobel [Sanal Pharma], Salinen Austria AG, Cheetham Salt and Sudsalz
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS